AIP
FMTX

Ameritas Investment Partners’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Ameritas Investment Partners’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,458
Closed -$49K – 3078
2022
Q3 		$49K Hold
2,458
– – ﹤0.01% 1995
2022
Q2 		$16K Hold
2,458
– – ﹤0.01% 2671
2022
Q1 		$23K Hold
2,458
– – ﹤0.01% 2509
2021
Q4 		$35K Hold
2,458
– – ﹤0.01% 2362
2021
Q3 		$57K Hold
2,458
– – ﹤0.01% 2074
2021
Q2 		$61K Hold
2,458
– – ﹤0.01% 2064
2021
Q1 		$69K Buy
2,458
+1,085
+79% +$39.1K ﹤0.01% 1890
2020
Q4 		$48K Hold
1,373
– – ﹤0.01% 2018
2020
Q3 		$68K Buy
+1,373
New +$55.5K ﹤0.01% 1658

Ameritas Investment Partners's FMTX Position: Q4 2022 in Review

Ameritas Investment Partners sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 2,458 shares — an estimated $49K sold.

Ameritas Investment Partners first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $69K in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Ameritas Investment Partners reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,458 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $49K.
  • Ameritas Investment Partners first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Ameritas Investment Partners's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $69K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.